Somatostatin analogs are an invaluable therapeutic option in the diagnosis and treatment of
somatotropinomas, thyrotropinomas, and functioning and non-functioning …

Context Hypoglycemia, occurring after bariatric and other forms of upper gastrointestinal
surgery, is increasingly encountered by clinical endocrinologists. The true frequency of this …

Abstract Potassium channels (K+-channels) selectively control the passive flow of potassium
ions across biological membranes and thereby also regulate membrane excitability. Genetic …

Congenital hyperinsulinism (CHI) is a heterogenous and complex disorder in which the
unregulated insulin secretion from pancreatic beta-cells leads to hyperinsulinaemic …

Congenital hyperinsulinism (CHI) is a condition characterised by severe and recurrent
hypoglycaemia in infants and young children caused by inappropriate insulin over …

Post‐bariatric hypoglycaemia (PBH) is a metabolic complication of bariatric surgery (BS),
consisting of low post‐prandial glucose levels in patients having undergone bariatric …

Hypoglycemia is the result of defects/impairment in glucose homeostasis. The main
etiological causes are metabolic and/or endocrine and/or other congenital disorders …

Congenital hyperinsulinism (CHI) is a rare disease characterized by an unregulated insulin
release, leading to hypoglycaemia. It is the most frequent cause of persistent and severe …

Mitochondrial uncoupling proteins (UCP) are a part of the large family of mitochondrial
solute carriers (SLC25s), concentrated in the inner mitochondrial membrane that carries …

Diazoxide is the first-line drug for treating hyperinsulinism and the only pharmacological
agent approved for hyperinsulinism by the Federal Drug Administration. This systemic …